Valeo Financial Advisors, LLC Organon & Co. Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$31.66 - $38.9 $235,835 - $289,766	-7,449 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$30.45 - $39.36 $204,928 - $264,892	-6,730 Reduced 47.46%	7,449 $260,000
Q4 2021 Jan 07, 2022	SELL	$28.67 - $37.13 $261,155 - $338,217	-9,109 Reduced 39.11%	14,179 $432,000
Q3 2021 Nov 02, 2021	BUY	$28.63 - $35.64 $52,192 - $64,971	1,823 Added 8.49%	23,288 $764,000
Q2 2021 Jul 22, 2021	BUY	$28.45 - $38.0 $610,679 - $815,670	21,465 New	21,465 $650,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.76B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.